Skip to main content
Top
Published in: Clinical and Experimental Nephrology 7/2019

01-07-2019 | IgA Vasculitis | Original article

A retrospective analysis of children with Henoch–Schonlein purpura and re-evaluation of renal pathologies using Oxford classification

Authors: Evrim Kargın Çakıcı, Gökçe Gür, Fatma Yazılıtaş, Fehime Kara Eroğlu, Tülin Güngör, Nilüfer Arda, Diclehan Orhan, Funda Seher Özalp Ateş, Mehmet Bülbül

Published in: Clinical and Experimental Nephrology | Issue 7/2019

Login to get access

Abstract

Background

Henoch–Schönlein purpura (HSP) is the most common vasculitis in childhood. The long-term prognosis is variable and depends on renal involvement. The aims of this study were to investigate the clinical and laboratory characteristics of our HSP patients, to identify the risk factors for the development of Henoch–Schönlein purpura nephritis (HSPN) and to assess the efficacy of the Oxford Classification system for predicting renal outcomes.

Methods

We performed a retrospective review of HSP patients who admitted to our center between 2001 and 2016, and were < 18 years on admission.

Results

A total of 1120 children with HSP were analyzed. Their mean age was 7.4 ± 3.4 years. At onset, purpura was present in all cases, arthritis/arthralgia in 42.4%, abdominal involvement in 39% and renal involvement in 37%. Risk factors for the development of nephritis were age ≥ 8 years, atypical distribution of purpura, ESR > 20 mm/h and abdominal pain. Renal biopsy was performed on 75 patients before immunosuppressive treatment. The mesangial score was strongly associated with proteinuria. Segmental glomerulosclerosis, tubular atrophy/interstitial fibrosis, and crescent formation of ≥ 50% were associated with reduced eGFR at the time of biopsy. A Kaplan–Meier plot showed that segmental glomerulosclerosis and tubular atrophy/interstitial fibrosis significantly predict poor renal outcome.

Conclusion

The long-term morbidity of HSP is predominantly attributed to renal involvement. Patients with HSP, who have a high risk to develop nephritis, could be followed for longer periods of time. The Oxford classification is useful in predicting long-term outcomes of HSPN.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603–6.CrossRef Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603–6.CrossRef
2.
go back to reference Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–41.CrossRef Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–41.CrossRef
3.
go back to reference Jauhola O, Ronkainen J, Koskimies O, et al. Outcome of Henoch–Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset. Pediatr Nephrol. 2012;27(6):933–9.CrossRef Jauhola O, Ronkainen J, Koskimies O, et al. Outcome of Henoch–Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset. Pediatr Nephrol. 2012;27(6):933–9.CrossRef
4.
go back to reference Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch–Schönlein purpura: a retrospective cohort study. Lancet. 2002;360(9334):666–70.CrossRef Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch–Schönlein purpura: a retrospective cohort study. Lancet. 2002;360(9334):666–70.CrossRef
5.
go back to reference Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, De Martino M. Henoch–Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum. 2005;35(3):143–53.CrossRef Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, De Martino M. Henoch–Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum. 2005;35(3):143–53.CrossRef
6.
go back to reference Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL. Renal manifestations in Henoch–Schönlein purpura: a 10-year clinical study. Pediatr Nephrol. 2005;20(9):1269–72.CrossRef Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL. Renal manifestations in Henoch–Schönlein purpura: a 10-year clinical study. Pediatr Nephrol. 2005;20(9):1269–72.CrossRef
7.
go back to reference Koskimies O, Mir S, Rapola J, Vilska J. Henoch–Schonlein nephritis: long-term prognosis of unselected patients. Arch Dis Child. 1981;56(6):482–4.CrossRef Koskimies O, Mir S, Rapola J, Vilska J. Henoch–Schonlein nephritis: long-term prognosis of unselected patients. Arch Dis Child. 1981;56(6):482–4.CrossRef
8.
go back to reference Kobayashi O, Wada H, Okawa K, Takeyama I. Schonlein–Henoch’s syndrome in children. Contrib Nephrol. 1975;4:48–71.CrossRef Kobayashi O, Wada H, Okawa K, Takeyama I. Schonlein–Henoch’s syndrome in children. Contrib Nephrol. 1975;4:48–71.CrossRef
9.
go back to reference Coppo R, Andrulli S, Amore A, et al. Predictors of outcome in Henoch–Schönlein nephritis in children and adults. Am J Kidney Dis. 2006;47(6):993–1003.CrossRef Coppo R, Andrulli S, Amore A, et al. Predictors of outcome in Henoch–Schönlein nephritis in children and adults. Am J Kidney Dis. 2006;47(6):993–1003.CrossRef
10.
go back to reference Cattran DC, Coppo R, Cook HT, et al. The Oxford Classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–45.CrossRef Cattran DC, Coppo R, Cook HT, et al. The Oxford Classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–45.CrossRef
11.
go back to reference Coppo R, Troyanov S, Camilla R, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010;77(10):921–7.CrossRef Coppo R, Troyanov S, Camilla R, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010;77(10):921–7.CrossRef
12.
go back to reference Alamartine E, Sauron C, Laurent B, et al. The use of the Oxford Classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol. 2011;6(10):2384–8.CrossRef Alamartine E, Sauron C, Laurent B, et al. The use of the Oxford Classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol. 2011;6(10):2384–8.CrossRef
13.
go back to reference Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am. 1987;34(3):571–90.CrossRef Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am. 1987;34(3):571–90.CrossRef
14.
go back to reference National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76.CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76.CrossRef
15.
go back to reference Hass M. Henoch–Schönlein purpura nephritis. In: Jennete JC, Olsen JL, Schwartz MM, Silva FG, editors. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 465–8. Hass M. Henoch–Schönlein purpura nephritis. In: Jennete JC, Olsen JL, Schwartz MM, Silva FG, editors. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 465–8.
16.
go back to reference Anil M, Aksu N, Kara OD, Bal A, Anil AB, Yavaşcan O, et al. Henoch–Schönlein purpura in children from western Turkey: a retrospective analysis of 430 cases. Turk J Pediatr. 2009;51(5):429–36.PubMed Anil M, Aksu N, Kara OD, Bal A, Anil AB, Yavaşcan O, et al. Henoch–Schönlein purpura in children from western Turkey: a retrospective analysis of 430 cases. Turk J Pediatr. 2009;51(5):429–36.PubMed
17.
go back to reference Calviño MC, Llorca J, García-Porrúa C, Fernández-Iglesias JL, Rodriguez-Ledo P, González-Gay MA. Henoch–Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore). 2001;80(5):279–90.CrossRef Calviño MC, Llorca J, García-Porrúa C, Fernández-Iglesias JL, Rodriguez-Ledo P, González-Gay MA. Henoch–Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore). 2001;80(5):279–90.CrossRef
18.
go back to reference Kaku Y, Nohara K, Honda S. Renal involvement in Henoch–Schönlein purpura: a multivariate analysis of prognostic factors. Kidney Int. 1998;53(6):1755–9.CrossRef Kaku Y, Nohara K, Honda S. Renal involvement in Henoch–Schönlein purpura: a multivariate analysis of prognostic factors. Kidney Int. 1998;53(6):1755–9.CrossRef
19.
go back to reference Kawasaki Y, Suzuki J, Sakai N, Nemoto K, Nozawa R, Suzuki S, Suzuki H. Clinical and pathological features of children with Henoch–Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol. 2003;60(3):153–60.CrossRef Kawasaki Y, Suzuki J, Sakai N, Nemoto K, Nozawa R, Suzuki S, Suzuki H. Clinical and pathological features of children with Henoch–Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol. 2003;60(3):153–60.CrossRef
20.
go back to reference Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch–Schonlein nephritis. Lancet. 1992;339(8788):280–2.CrossRef Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch–Schonlein nephritis. Lancet. 1992;339(8788):280–2.CrossRef
21.
go back to reference Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch–Schonlein purpura. Eur J Pediatr. 2002;161(4):196–201.CrossRef Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch–Schonlein purpura. Eur J Pediatr. 2002;161(4):196–201.CrossRef
22.
go back to reference Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A. Predictive factors of renal involvement or relapsing disease in children with Henoch–Schonlein purpura. Rheumatol Int. 2005;25(1):45–8.CrossRef Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A. Predictive factors of renal involvement or relapsing disease in children with Henoch–Schonlein purpura. Rheumatol Int. 2005;25(1):45–8.CrossRef
23.
go back to reference Bogdanovic R. Henoch–Schonlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr. 2009;98(12):1882–9.CrossRef Bogdanovic R. Henoch–Schonlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr. 2009;98(12):1882–9.CrossRef
24.
go back to reference Mollica F, Li Volti S, Garozzo R, et al. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr. 1992;151(2):140–4.CrossRef Mollica F, Li Volti S, Garozzo R, et al. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr. 1992;151(2):140–4.CrossRef
25.
go back to reference Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormälä T, Turtinen J, Nuutinen M. Early prednisone therapy in Henoch–Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149(2):241–7.CrossRef Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormälä T, Turtinen J, Nuutinen M. Early prednisone therapy in Henoch–Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149(2):241–7.CrossRef
26.
go back to reference Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Hölttä T, Jahnukainen T, Rajantie J, Ormälä T, Turtinen J, Nuutinen M. Renal manifestations of Henoch–Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child. 2010;95(11):877–82.CrossRef Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Hölttä T, Jahnukainen T, Rajantie J, Ormälä T, Turtinen J, Nuutinen M. Renal manifestations of Henoch–Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child. 2010;95(11):877–82.CrossRef
27.
go back to reference Fretzayas A, Sionti I, Moustaki M, et al. Henoch–Schönlein purpura: a long-term prospective study in Greek children. J Clin Rheumatol. 2008;14(6):324–31.CrossRef Fretzayas A, Sionti I, Moustaki M, et al. Henoch–Schönlein purpura: a long-term prospective study in Greek children. J Clin Rheumatol. 2008;14(6):324–31.CrossRef
28.
go back to reference Edstrom Halling S, Soderberg MP, Berg UB. Predictors of outcome in Henoch–Schonlein nephritis. Pediatr Nephrol. 2010;25(6):1101–8.CrossRef Edstrom Halling S, Soderberg MP, Berg UB. Predictors of outcome in Henoch–Schonlein nephritis. Pediatr Nephrol. 2010;25(6):1101–8.CrossRef
29.
go back to reference Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch–Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005;90(9):916–20.CrossRef Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch–Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005;90(9):916–20.CrossRef
32.
go back to reference Algoet C, Proesmans W. Renal biopsy 2–9 years after Henoch–Schonlein purpura. Pediatr Nephrol. 2003;18(5):471–3 (Epub 2003 Apr 3).PubMed Algoet C, Proesmans W. Renal biopsy 2–9 years after Henoch–Schonlein purpura. Pediatr Nephrol. 2003;18(5):471–3 (Epub 2003 Apr 3).PubMed
Metadata
Title
A retrospective analysis of children with Henoch–Schonlein purpura and re-evaluation of renal pathologies using Oxford classification
Authors
Evrim Kargın Çakıcı
Gökçe Gür
Fatma Yazılıtaş
Fehime Kara Eroğlu
Tülin Güngör
Nilüfer Arda
Diclehan Orhan
Funda Seher Özalp Ateş
Mehmet Bülbül
Publication date
01-07-2019
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 7/2019
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-019-01726-5

Other articles of this Issue 7/2019

Clinical and Experimental Nephrology 7/2019 Go to the issue